Pharma Journalist 7836 posts 0 comments

Delivra has entered into a technology licensing agreement with Kalytera Therapeutics. Based in California, Kalytera is a pharmaceutical company developing a portfolio of…
Read More...

Integral Molecular has developed an ultra high-throughput microfluidic B-cell cloning technology that can interrogate tens of millions of immune cells (B-cells), enabling deep mining of…
Read More...

PaizaBio has secured an agreement with Taiwan-based JHL Biotech to provide fill-finish services for multiple JHL projects. New Mexico-based PaizaBio will provide these services to…
Read More...

Bayer and ERS signed a patent license agreement whereby Bayer gains access to ERS’ CRISPR-Cas9 genome-editing patents for certain cross-divisional applications in Bayer’s core strategic…
Read More...

As one of medicine’s largest challenges, viral infections often escape vaccines due to their natural ability to mutate rapidly and develop drug resistance easily. Many viruses, such as…
Read More...

In an advance that could lead to the development of better treatments for viral pathogens, such as Zika, a team of scientists at the California NanoSystems Institute at UCLA are…
Read More...

International Biotechnology Center "Generium", (LLC IBC Generium), a private scientific research company in Russia that is committed to developing and delivering innovative, effective,…
Read More...

biOasis Technologies has entered into a License Agreement to collaborate with Astellas Research Institute of America (Astellas). The terms of the agreement, for competitive reasons,…
Read More...

Bristol-Myers Squibb has selected the Medidata Clinical Cloud to help manage, monitor and analyze its clinical trials. Medidata's cutting-edge technology platform will support…
Read More...

TierPoint, a leading national provider of hybrid IT solutions, announced that it has been selected by GlaxoSmithKline (GSK) to support the company's global data consolidation and…
Read More...